The Tulane Transplant Institute has been named a Center of Excellence (COE) for liver, kidney, and pancreas transplants by Optum, a leading health services company. The COE designation recognizes organizations that provide high-quality, cost-effective care to patients receiving organ transplants.
Tulane earned the COE designations after completing a rigorous qualification process that took several factors into consideration, including a history of delivering excellent health outcomes – as measured by fewer health complications and hospital readmissions, among others – in a cost-effective manner.
“Few healthcare services require the highest levels of expertise, cooperation and patient follow-up as does a transplantation program,” said Robert Lynch, MD, Tulane Health System’s CEO. “The Tulane Transplant Institute not only meets these requirements but exceeds them. We are appreciative of this Center of Excellence designation for recognizing that hard work.”
“We selected the Tulane Transplant Institute as our newest Center of Excellence because of its commitment to providing outstanding care to patients receiving an organ transplant,” said Jon Friedman, MD, chief medical officer at Optum for Medical Benefit Management. “We commend the Tulane transplant team for its excellence in providing the highest quality care for their patients.”